This introduction to Pharmutopia: How Drug Regulation Fails Patients and What We Can Do About It explores the complex interplay between pharmaceutical knowledge, government regulation, and individual autonomy in the United States. The text argues that Americans’ unprecedented consumption of pharmaceuticals is the product of a century-long alliance between medical professionals seeking to eliminate competition and a federal government expanding its regulatory domain. This alliance forged the concepts of “pharmaceutical fact”—the regulatory structures defining drug legitimacy—and “pharmaceuticalization,” the process by which increasing aspects of human life are framed as pharmaceutical problems. These frameworks, the author contends, are not neutral but constitute a sociopolitical system that determines who has authority over medical decisions and the limits of personal autonomy. Drawing on the work of Thomas Szasz, the critique highlights the evolution of the “Therapeutic State,” where state power and medical authority become inseparably linked, resulting in surveillance, behavioral control, and exclusion from necessary medicines for those outside the system. The book traces how professional organizations, in partnership with federal agencies, used regulation to enforce their definitions of scientific fact, transforming both the nature of medicines and the roles of those who dispense them. Through the lens of Nico Stehr’s “knowledge capitalism,” the text demonstrates that pharmaceutical knowledge has been turned into monopoly property, enforced through legal and regulatory mechanisms like the FDA and international agreements such as TRIPS. This transformation, the author asserts, underlies the economic and social power of the pharmaceutical industry, shaping access to medicines and the governance of individual bodies. The introduction frames the book’s central inquiry: whether the current system serves patients or entrenches a regime of knowledge monopolism and state authority.